Purchases and Sales Made in Q2 2022 in Apellis Pharmaceuticals, Inc. (APLS)
This table provides information about the institutional ownership of Apellis Pharmaceuticals, Inc. (APLS) during Q2 2022. The information is specifically focused on institutions that hold shares of Apellis Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 11, 2022
Q2 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-29.7K- 53.51% |
$1.04M - $1.76M
|
25.8K
$856K
|
|
Aug 12, 2022
Q2 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-30.6K- 24.78% |
$1.07M - $1.81M
|
92.9K
$3.08M
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-31K- 95.48% |
$1.09M - $1.84M
|
1.47K
$48.7K
|
|
Aug 12, 2022
Q2 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-38.5K- 9.87% |
$1.35M - $2.28M
|
352K
$11.7M
|
|
Aug 15, 2022
Q2 2022
|
Man Group PLC
London, X0 |
SELL
|
- |
-40.3K- 63.16% |
$1.41M - $2.39M
|
23.5K
$780K
|
|
Aug 15, 2022
Q2 2022
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-40.4KClosed |
$1.42M - $2.39M
|
0
$0
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-42.5K- 37.09% |
$1.49M - $2.52M
|
72.1K
$2.39M
|
|
Aug 15, 2022
Q2 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-47.6K- 90.06% |
$1.67M - $2.82M
|
5.26K
$174K
|
|
Aug 15, 2022
Q2 2022
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-51.2KClosed |
$1.8M - $3.03M
|
0
$0
|
|
Jul 19, 2022
Q2 2022
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-58.3K- 48.9% |
$2.05M - $3.45M
|
61K
$2.02M
|
|
Feb 14, 2023
Q2 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-68.2K- 46.55% |
$2.39M - $4.04M
|
78.3K
$2.6M
|
|
Aug 15, 2022
Q2 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-73.4KClosed |
$2.58M - $4.35M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
- |
-104KClosed |
$3.65M - $6.16M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-165K- 49.54% |
$5.77M - $9.74M
|
168K
$5.56M
|
|
Aug 12, 2022
Q2 2022
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-167K- 44.3% |
$5.86M - $9.89M
|
210K
$6.96M
|
|
Aug 15, 2022
Q2 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-175K- 15.56% |
$6.14M - $10.4M
|
950K
$31.5M
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-192K- 15.18% |
$6.74M - $11.4M
|
1.07M
$35.6M
|
|
Aug 11, 2022
Q2 2022
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-200KClosed |
$7.01M - $11.8M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-221KClosed |
$7.76M - $13.1M
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-232K- 54.0% |
$8.13M - $13.7M
|
197K
$6.54M
|
|
Aug 15, 2022
Q2 2022
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-250KClosed |
$8.77M - $14.8M
|
0
$0
|
|
Aug 12, 2022
Q2 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-306K- 87.94% |
$10.7M - $18.1M
|
41.9K
$1.39M
|
|
Aug 02, 2022
Q2 2022
|
Jennison Associates LLC
|
SELL
|
- |
-406K- 15.01% |
$14.2M - $24M
|
2.3M
$76.2M
|
|
Aug 01, 2022
Q2 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-627K- 47.31% |
$22M - $37.1M
|
698K
$23.1M
|
|
Aug 15, 2022
Q2 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.16M- 78.32% |
$40.7M - $68.7M
|
321K
$10.6M
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-2.66M- 18.71% |
$93.2M - $157M
|
11.5M
$383M
|